Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Epigallocatechin-3-Gallate as Adjunctive Locally Delivered Nanotherapeutic in Stage II Periodontitis
NCT07754253Phase 1Recruiting
- Sponsor
- Mansoura University
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial of epigallocatechin gallate in periodontitis (3 arms), sponsored by Mansoura University. Primary endpoint: Pocket Depth Reduction at 3 months. Started Mar 2026; status: recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07754253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07754253.